Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-27

FDA Approved: BEXAROTENE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved the original application for BEXAROTENE from Amneal Pharmaceuticals NY LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bexarotene (Bexarotene)

Snippet

ORIG AP for BEXAROTENE (BEXAROTENE)